UnitLevel 2Undergraduate

BPS2042 Drug development

Faculty of Pharmacy and Pharmaceutical Sciences

BPS2042 Drug development is a level 2, 6-credit-point, undergraduate unit from the Faculty of Pharmacy and Pharmaceutical Sciences, offered in 2023 in Semester 2 at Parkville. It has no prerequisites and unlocks 1 unit, leading on to 2 units in all.

Credit points
6
Offered in 2023
Semester 2
Parkville
Assessment
No exam
3 tasks

This is the 2023 handbook entry. See the 2027 entry.

Reviews

No reviews yet

No reviews yet. Be the first to review BPS2042.

Requisites

Before BPS2042

No prerequisites or corequisites.

After BPS2042

1 unit list BPS2042 as a prerequisite or corequisite.

Overview

This unit will take you through the process of developing a drug candidate into a registered pharmaceutical product. This encompasses: pre-clinical development, including drug formulation based on the pharmacokinetic, pharmacodynamic and toxicological profile of a drug candidate; clinical trial regulation and design; intellectual property and marketing considerations. You will be introduced to the regulatory and commercial requirements as well as the scientific concepts underpinning the drug development processes. This unit also explores a range of career paths available in the pharmaceutical industry.

Offerings in 2023

Teaching periodCampusMode
Second semesterParkvilleOn campus

Assessment

  • Online quizzesOther
    60%
  • Career's AssignmentAssignment
    10%
  • Group PresentationPresentation
    30%

Learning outcomes

When you finish this unit, you should be able to:

  1. 1

    Explain the scientific and regulatory stages involved in taking a drug candidate to a registered pharmaceutical product.

  2. 2

    Explain the basis of pre-formulation tests to inform formulation decisions.

  3. 3

    Evaluate formulation options for a drug candidate with regard to medical, technical and commercialisation considerations.

  4. 4

    Propose pre-clinical tests for a drug candidate to provide evidence for its safety.

  5. 5

    Differentiate between the phases of a clinical trial.

  6. 6

    Discuss the commercial lifecycle of a pharmaceutical product, the importance of intellectual property and marketing considerations.

  7. 7

    Identify and describe a range of jobs that exist in the pharmaceutical industry.

Workload and teaching

  • Assessments2 hours
  • Applied sessions12 hours
  • Workshops24 hours
  • Teaching approachActive learning
  • Teaching approachCase-based teaching
  • Twelve 1-hour online preparation modules (Discovery)
  • Twenty-four 1-hour interactive lectures (online modules)
  • Twelve 1-hour applied sessions (Q&A)
  • Ten 2-hour workshops
  • One 4-hour workshop (GMP)

Workshops will use primarily group work to work through case studies in different aspects of the drug development process

Learning resources

Technology resources

For more information on Bring Your Own Device (BYOD) specifications and the technology systems and services available to students, review the Student Technology Essentials Handbook https://www.monash.edu/__data/assets/pdf_file/0010/1041220/student-it-brochure.pdf

Contacts

Chief Examiners
Professor Michelle McIntosh
Unit Coordinators
Professor Michelle McIntosh

Common questions

What are the prerequisites for BPS2042?

BPS2042 has no prerequisites.

What can I take after BPS2042?

BPS2042 is a prerequisite or corequisite for 1 unit, including BPS3051. Those lead on to 2 units in all.

When is BPS2042 offered?

In 2023, BPS2042 runs in Semester 2 at Parkville.

Does BPS2042 have an exam?

No. BPS2042 has 3 assessment tasks and no exam.

More details

Credit points
6
Level
2
Study level
Undergraduate
Faculty
Faculty of Pharmacy and Pharmaceutical Sciences
Type
Coursework
EFTSL
0.125
Student contribution
SCA Band 2
Study abroad
Available